%0 Journal Article
%T The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C
%A Hermann E Wasmuth
%A Christian Stolte
%A Andreas Geier
%A Christoph G Dietrich
%A Carsten Gartung
%A Johann Lorenzen
%A Siegfried Matern
%A Frank Lammert
%J BMC Infectious Diseases
%D 2004
%I BioMed Central
%R 10.1186/1471-2334-4-4
%X Anti-nuclear, anti-smooth muscle, anti-mitochondrial, anti-neutrophil-cytoplasmatic and anti-liver/kidney microsomal antibodies were determined in 78 consecutive anti-HCV positive patients by indirect immunofluorescence. The presence of these antibodies was related to demographic variables and to the outcome of antiviral combination therapy with interferon-¦Á and ribavirin in 65 patients.In our study, positivity for autoantibodies was associated with higher alanine aminotransferase levels and higher mean values for HCV-RNA (p < 0.01). Furthermore, negativity for non-organ-specific autoantibodies was associated with a favourable treatment outcome of combination therapy with at least one negative RT-PCR for HCV-RNA during treatment (OR 4.65, 95% CI 1.31 to 16.48, p = 0.02). ANA and SMA staining patterns and titers were not correlated to treatment response. With multiple logistic regression analysis, positivity for autoantibodies and HCV genotype were independently associated with outcome of antiviral combination therapy (p = 0.02).The absence of non-organ-specific autoantibodies might indicate a significantly higher chance for viral clearance in response to combination therapy for chronic hepatitis C infection. Therefore, despite of an overall higher treatment response, the addition of the immunomodulatory drug ribavirin could accentuate immunological differences that affect treatment outcome and might have been less obvious in earlier studies analysing interferon monotherapy.Various immunological phenomena have been described in patients being exposed to the hepatitis C virus (HCV) [1]. Organ-specific and non-organ-specific autoantibodies are found in a considerable number of patients with acute and chronic hepatitis C [2]. Especially the high percentage of non-organ-specific autoantibodies (NOSA) in chronic infection has led to further investigation of the potential biological relevance of these findings. In recent studies the prevalence of different NOSA, including
%K Antiviral therapy
%K chronic hepatitis C
%K interferon-¦Á
%K non-organ-specific autoantibodies
%K ribavirin
%U http://www.biomedcentral.com/1471-2334/4/4